Table 2.
Participant characteristics
| Overall (n=50) | |
|---|---|
| Gender (male, n (%)) | 26 (52%) |
| Age (years), median [IQR] | 71 [63–77] |
| Age (years), range | 44–84 |
| Colinet Comorbidity Score, median [IQR] | 10.5 [6.75–12.25] |
| ARISCAT, n (%) | |
| Intermediate risk | 27 (54%) |
| High risk | 23 (46%) |
| At risk of malnutrition, n (%)a | |
| Yes | 16 (40%) |
| No | 27 (63%) |
| Cancer type, n (%) | |
| Colorectal | 32 (64%) |
| Oesophageal | 9 (18%) |
| Sarcoma | 6 (12%) |
| Pancreatic | 1 (2%) |
| Prostate | 1 (2%) |
| Gastric | 1 (2%) |
| Surgery type, n (%) | |
| Bowel resection | 12 (24%) |
| Oesophagectomy | 9 (18%) |
| Cytoreductive surgery with HIPEC | 8 (16%) |
| Pelvic exenteration | 6 (12%) |
| Ultra-low anterior resection | 6 (12%) |
| Sarcoma resection | 3 (6%) |
| Pancreatectomy | 1 (2%) |
| Prostatectomy | 1 (2%) |
| Gastrectomy | 1 (2%) |
| Debulking surgery | 1 (2%) |
| Reversal of Hartmans | 1 (2%) |
| Whipples operation | 1 (2%) |
| CPET-derived variables | |
| AT (mL/kg/min), mean±SD | 9.8±1.8 |
| VO2 Peak (mL/kg/min), mean±SD | 14.0±2.9 |
| VO2 Peak/BSA (mLs/kg), mean±SD | 578±121 |
| Smoking status, n (%) | |
| Never smoked | 13 (26%) |
| Quit smoking >2 months | 32 (64%) |
| Current smoker | 5 (10%) |
| Living situation, n (%) | |
| Living alone | 9 (18%) |
| Living with family | 41 (82%) |
| Residing >30km from hospital, n (%) | 34 (68%) |
| Reported currently not exercising, n (%) | 40 (80%) |
Abbreviations: ARISCAT Assess Respiratory Risk in Surgical Patients in Catalonia, BSA body surface area, CPET cardiopulmonary exercise test, HIPEC hyperthermic intraperitoneal chemotherapy. an=43, 7 missing Malnutrition Screening Tool Results